Cargando…
Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990985/ http://dx.doi.org/10.1186/2051-1426-1-S1-P273 |
| _version_ | 1782312359591673856 |
|---|---|
| author | Iversen, Trine Z Engell-Noerregaard, Lotte Ellebaek, Eva Andersen, Rikke Larsen, Stine K Bjoern, Jon Zeyher, Claus Gouttefangeas, Cécile Thomsen, Birte M Holm, Bente Straten, Per thor Mellemgaard, Anders Andersen, Mads H Svane, Inge M |
| author_facet | Iversen, Trine Z Engell-Noerregaard, Lotte Ellebaek, Eva Andersen, Rikke Larsen, Stine K Bjoern, Jon Zeyher, Claus Gouttefangeas, Cécile Thomsen, Birte M Holm, Bente Straten, Per thor Mellemgaard, Anders Andersen, Mads H Svane, Inge M |
| author_sort | Iversen, Trine Z |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3990985 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39909852014-05-01 Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase Iversen, Trine Z Engell-Noerregaard, Lotte Ellebaek, Eva Andersen, Rikke Larsen, Stine K Bjoern, Jon Zeyher, Claus Gouttefangeas, Cécile Thomsen, Birte M Holm, Bente Straten, Per thor Mellemgaard, Anders Andersen, Mads H Svane, Inge M J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3990985/ http://dx.doi.org/10.1186/2051-1426-1-S1-P273 Text en Copyright © 2013 Iversen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Iversen, Trine Z Engell-Noerregaard, Lotte Ellebaek, Eva Andersen, Rikke Larsen, Stine K Bjoern, Jon Zeyher, Claus Gouttefangeas, Cécile Thomsen, Birte M Holm, Bente Straten, Per thor Mellemgaard, Anders Andersen, Mads H Svane, Inge M Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase |
| title | Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase |
| title_full | Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase |
| title_fullStr | Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase |
| title_full_unstemmed | Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase |
| title_short | Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase |
| title_sort | long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an hla-a2-restricted epitope derived from indoleamine 2,3 dioxygenase |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990985/ http://dx.doi.org/10.1186/2051-1426-1-S1-P273 |
| work_keys_str_mv | AT iversentrinez longlastingdiseasestabilizationintheabsenceoftoxicityinmetastaticlungcancerpatientsvaccinatedwithanhlaa2restrictedepitopederivedfromindoleamine23dioxygenase AT engellnoerregaardlotte longlastingdiseasestabilizationintheabsenceoftoxicityinmetastaticlungcancerpatientsvaccinatedwithanhlaa2restrictedepitopederivedfromindoleamine23dioxygenase AT ellebaekeva longlastingdiseasestabilizationintheabsenceoftoxicityinmetastaticlungcancerpatientsvaccinatedwithanhlaa2restrictedepitopederivedfromindoleamine23dioxygenase AT andersenrikke longlastingdiseasestabilizationintheabsenceoftoxicityinmetastaticlungcancerpatientsvaccinatedwithanhlaa2restrictedepitopederivedfromindoleamine23dioxygenase AT larsenstinek longlastingdiseasestabilizationintheabsenceoftoxicityinmetastaticlungcancerpatientsvaccinatedwithanhlaa2restrictedepitopederivedfromindoleamine23dioxygenase AT bjoernjon longlastingdiseasestabilizationintheabsenceoftoxicityinmetastaticlungcancerpatientsvaccinatedwithanhlaa2restrictedepitopederivedfromindoleamine23dioxygenase AT zeyherclaus longlastingdiseasestabilizationintheabsenceoftoxicityinmetastaticlungcancerpatientsvaccinatedwithanhlaa2restrictedepitopederivedfromindoleamine23dioxygenase AT gouttefangeascecile longlastingdiseasestabilizationintheabsenceoftoxicityinmetastaticlungcancerpatientsvaccinatedwithanhlaa2restrictedepitopederivedfromindoleamine23dioxygenase AT thomsenbirtem longlastingdiseasestabilizationintheabsenceoftoxicityinmetastaticlungcancerpatientsvaccinatedwithanhlaa2restrictedepitopederivedfromindoleamine23dioxygenase AT holmbente longlastingdiseasestabilizationintheabsenceoftoxicityinmetastaticlungcancerpatientsvaccinatedwithanhlaa2restrictedepitopederivedfromindoleamine23dioxygenase AT stratenperthor longlastingdiseasestabilizationintheabsenceoftoxicityinmetastaticlungcancerpatientsvaccinatedwithanhlaa2restrictedepitopederivedfromindoleamine23dioxygenase AT mellemgaardanders longlastingdiseasestabilizationintheabsenceoftoxicityinmetastaticlungcancerpatientsvaccinatedwithanhlaa2restrictedepitopederivedfromindoleamine23dioxygenase AT andersenmadsh longlastingdiseasestabilizationintheabsenceoftoxicityinmetastaticlungcancerpatientsvaccinatedwithanhlaa2restrictedepitopederivedfromindoleamine23dioxygenase AT svaneingem longlastingdiseasestabilizationintheabsenceoftoxicityinmetastaticlungcancerpatientsvaccinatedwithanhlaa2restrictedepitopederivedfromindoleamine23dioxygenase |